News
-
-
PRESS RELEASE
Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
Moderna's mRNA-4359 advances to Phase 2 in CPI-R/R melanoma patients. Promising data on tumor response rates and safety presented at ESMO Congress 2025 -
PRESS RELEASE
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group
New to The Street announces nationwide broadcast featuring Roadzen Inc., Metaterra Holdings, NRx Pharmaceuticals, Blackbarn NYC, and Melanie Soloway. Show highlights public and private companies shaping industries -
-
-
-
-
-
-